Brain Tumors and the Chemistry of Photodynamic Therapy
Biointerface Research in Applied Chemistry · 15.04.2026 · 16 (2)
DOI: 10.33263/briac162.065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biointerface Research in Applied Chemistry, online erschienen am 15.04.2026. Verfasst von Piotr Wańczura und 7 weiteren Autor:innen. Die Arbeit nennt 326 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Photodynamic therapy (PDT) offers a promising, minimally invasive treatment for central nervous system tumors, including glioblastoma and meningiomas. It works by activating photosensitizers with light, generating reactive oxygen species that selectively destroy tumor cells. Recent advancements in photosensitizers, nanomedicine, and combination therapies have improved efficacy and reduced side effects. Despite ongoing challenges in clinical implementation, PDT demonstrates significant potential in improving prognosis and quality of life in patients with aggressive brain tumors.
Zitieren
APA
Wańczura, P., Aebisher, D., Inglot, J., Myśliwiec, A., Mytych, W., Dynarowicz, K., Leś, D., & Bartusik-Aebisher, D. (2026). Brain Tumors and the Chemistry of Photodynamic Therapy. Biointerface Research in Applied Chemistry, 16(2). https://doi.org/10.33263/briac162.065
Vancouver
Wańczura P, Aebisher D, Inglot J, Myśliwiec A, Mytych W, Dynarowicz K, et al. Brain Tumors and the Chemistry of Photodynamic Therapy. Biointerface Research in Applied Chemistry. 2026;16(2). doi:10.33263/briac162.065
BibTeX
@article{Waczura2026,
author = {Wańczura, Piotr and Aebisher, David and Inglot, Jadwiga and Myśliwiec, Angelika and Mytych, Wiktoria and Dynarowicz, Klaudia and Leś, Dominika and Bartusik-Aebisher, Dorota},
title = {Brain Tumors and the Chemistry of Photodynamic Therapy},
journal = {Biointerface Research in Applied Chemistry},
year = {2026},
volume = {16},
number = {2},
doi = {10.33263/briac162.065}
}
EUVIMED